Overview

Bioequivalence Study Between Adagrasib Reference Tablets and High Drug Load Tablets

Status:
COMPLETED
Trial end date:
2025-06-19
Target enrollment:
Participant gender:
Summary
This is a study to evaluate bioequivalence between adagrasib reference tablets and high drug load tablets in healthy adult participants.
Phase:
PHASE1
Details
Lead Sponsor:
Mirati Therapeutics Inc.
Treatments:
adagrasib